title: Neutrophil-rich Ki-1-positive anaplastic large cell lymphoma: a study by fine-needle aspiration biopsy.
abstract: Fine-needle aspiration biopsy (FNAB) is an accurate, cost-effective method of evaluating lymphomas. The neutrophil-rich variant of anaplastic large cell lymphoma (NR-ALCL) is a rare non-Hodgkin lymphoma. To our knowledge, we present thefirst study of NR-ALCL by FNAB cytology. Histologic confirmation was available for both patients. Both cases were positive for Ki-1 (CD-30) and were either T-cell or null-cell phenotype. FNAB specimens were highly cellular with a single-cell pattern composed of pleomorphic tumor cells, "hallmark" tumor cells, and a background rich in neutrophils that occasionally obscured tumor cells. Diagnosis on FNAB is difficult owing to the rarity of this tumor, its resemblance to Hodgkin lymphoma and other non-Hodgkin lymphomas that express CD30, its similarity to an infectious process, and its occasional confusion with metastatic carcinoma and melanoma. Reproducible cytologic features usually are present, and the diagnosis can be made conclusively by FNAB in conjunction with ancillary studies.
authors.affiliation: Department of Pathology, Wake Forest University, Baptist Medical Center, Winston-Salem, NC, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Creager
authors.forename: Kim R
authors.initials: KR
authors.lastname: Geisinger
authors.forename: Simon
authors.initials: S
authors.lastname: Bergman
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001707:Biopsy, Needle; D002277:Carcinoma / Q000556:secondary; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007239:Infections / Q000473:pathology; D019394:Ki-67 Antigen / Q000032:analysis; D008215:Lymphocytes, Null / Q000473:pathology; D017728:Lymphoma, Large-Cell, Anaplastic / Q000737:chemistry / Q000473:pathology* / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000737:chemistry / Q000473:pathology; D008545:Melanoma / Q000556:secondary; D009364:Neoplasm Recurrence, Local; D009504:Neutrophils / Q000473:pathology*; D011241:Prednisone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D013601:T-Lymphocytes / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D019394:Ki-67 Antigen; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone